Work

Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study

Year: 2017

Type: article

Study design: Study Protocol

Source: Seminars in Arthritis and Rheumatism

DOI: 10.1016/j.semarthrit.2017.02.003

Authors: Jeffrey A. Sparks, Medha Barbhaiya, Elizabeth W. Karlson, Susan Y. Ritter, Soumya Raychaudhuri, Cassandra C. Corrigan, Fengxin Lu, Jacob Selhub, Daniel I. Chasman, Nina P. Paynter, Paul M. Ridker, Daniel H. Solomon

Institutions: Brigham and Women's Hospital, Harvard University, Broad Institute, Massachusetts Institute of Technology, Tufts University, Jean Mayer Human Nutrition Research Center on Aging

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state, G1737560575, G2471007954, Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study, G5981859630, Joint Biology Consortium Resource-based Center, G932915660

OpenAlex ID: W2586387248

FWCI: 3.114

Cites: 79

Cited by: 36

Related to: 10